2Davenport MS, Dillman JR, Cohan RH, et al. Effect of abrupt substitution of gadobenate dimeglumine for gadopentetate dimeglumine on rate of allergic-like reactions[J]. Radiology, 2013, 266(3): 773-782.
2Roos D. What is the randomised evidence for surgery and stereotactic radiosurgery for patients with solitary (or few) brain metastases[J]? Int J Evid Based Healthc, 2011, 9(1): 61-6.
3Seute T, Leffers P, ten Velde GP, et al. Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI)[J]. Cancer, 2008, 112(8): 1827-34.
4Essig M, Tartaro A, Tartaglione T, et al. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators[J]. Acad Radiol, 2006, 13(6): 744-51.
5Colosimo C, Demaerel P, Tortori-Donati P, et al. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children[J]. Pediatr Radiol, 2005, 35(5): 501-10.
6Lee SS, Ahn JH, Kim MK, et al. Brain metastases in breast cancer: prognostic factors and management [J]. Breast Cancer Res Treat, 2008, 111(3): 523-30.
7Sze G, Milano E, Johnson C, et al. Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT[J]. AJNR Am J Neuroradiol, 1990, 11 (4): 785-91.
8Gerretsen SC, le Maire TF, Miller S, et al. Multicenter, double- blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries [J]. Radiology, 2010, 255(3): 988-1000.
9Mathews VP, Caldemeyer KS, Ulmer JL, et al. Effects of contrast dose, delayed imaging, and magnetization transfer saturation on gadolinium-enhanced MR imaging of brain lesions [J]. J Magn Reson Imaging, 1997, 7(1): 14-22.
10Colosimo C, Rusealleda J, Korves M, et al. Detection of intracranial metastases: a multicenter, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dosage[J]. Invest Radiol, 2001, 36(2): 72-81.
